What Zeal Specialty Pharmacy does

Zeal Specialty Pharmacy (legal entity Zeal SP, LLC) is a U.S. specialty pharmacy founded in March 2023 and publicly launched in July 2023, headquartered in Pittsburgh, PA with a redundant fulfillment site in Peachtree Corners, GA. The company focuses on rare-disease and orphan-drug therapies, operating as a dually accredited (URAC and ACHC), nationwide-licensed (all 50 states plus DC, Puerto Rico, and the U.S. Virgin Islands) pharmacy that has completed 23+ orphan drug launches, including ultra-orphan pediatric therapies. It serves three primary customer segments — patients with rare and orphan diseases, prescribers and care teams, and pharmaceutical manufacturers — coordinating benefits investigation, prior authorization, financial assistance, and direct-to-patient medication delivery.

The company is built on a proprietary, cloud-based patient services platform called OnQueue, which offers configurable trigger-based workflows and real-time visibility from referral through refill, augmented by an AI system branded ETHEL that processes new prescriptions around the clock. Smart device integration and validated clinical questionnaires are part of the platform's reported capabilities, with announced future additions including conversational AI and pharmacy dispensing robotics. The technology is described as purpose-built for specialty pharmacy rather than retrofitted from a general-purpose system, and it underpins both internal operations and the manufacturer-facing data feed.

Revenue is generated primarily through specialty pharmacy dispensing billed to insurance, Medicare, and Medicaid, with a secondary managed services stream from pharmaceutical manufacturer partnerships offered under integrated and ecosystem models. Go-to-market is B2B-focused enterprise field sales targeting prescribers and manufacturers, with omnichannel patient support delivered via phone, fax, e-prescribe (NPI 1093424905), and direct home delivery. The company is privately held and operator-owned by co-founders Jonathan Ogurchak (CEO, PharmD) and Brenden Harper (CFO), with no disclosed institutional funding rounds, parent company, or M&A activity.

Name

Zeal Specialty Pharmacy

Legal name

Zeal SP, LLC

Website

https://zealsp.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

U.S. nationwide specialty pharmacy licensed in all 50 states and dually accredited by URAC and ACHC, focusing on rare-disease and orphan-drug therapies with 23+ launches completed. Built on a proprietary OnQueue platform and ETHEL AI for 24/7 prescription processing, serving patients, prescribers, and pharmaceutical manufacturers.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy

NAICS

Pharmacies and Drug Retailers (45611), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Retail-Drug Stores And Proprietary Stores (5912), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC)

akta.pro secondary industries

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Medication Therapy Management (MTM) & Clinical Pharmacy Services (HLAFALAH)

Keywords

• Specialty pharmacy services
• Rare disease therapies
• Prior authorization management
• Orphan drug distribution
• Patient support services

Headquarters

HQ city

Pittsburgh

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Pharmacy Dispensing: Provides specialty pharmaceutical services to patients with rare and orphan diseases. Handles complex therapies requiring prior authorizations, benefits investigation, and specialized handling. Revenue generated through prescription dispensing, typically billed to insurance/Medicare/Medicaid.
2. Manufacturer Partnership Services: Partners with pharmaceutical manufacturers for therapy access, patient engagement, and specialized distribution. Offers flexible models including integrated and ecosystem approaches.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Zeal Specialty Pharmacy is a nationwide specialty pharmacy focused on rare-disease and complex therapies. The company dispenses specialty medications directly to patients and prescriber offices, handling benefits investigation, prior authorizations and appeals, financial-assistance navigation, and home delivery. It also partners with pharmaceutical manufacturers to provide therapy access, patient engagement, and limited-distribution drug support. Operations are powered by a proprietary cloud-based platform (OnQueue) and an AI system (ETHEL) that automates 24/7 prescription processing.

Product overview

Zeal Specialty Pharmacy operates as a nationwide specialty pharmacy for rare disease and complex therapies, built on its proprietary technology platform. The core offering consists of the OnQueue patient-services platform and ETHEL AI automation system, which together provide real-time referral-to-refill visibility and 24/7 prescription processing. The company offers patient support services (insurance navigation, prior authorizations, medication delivery), prescriber services (benefits investigation, appeals), and manufacturer partnership programs. Coming soon are conversational AI and pharmacy dispensing robotics. The company supports 23+ orphan drug launches and dispenses specialty medications including Ilumya, Unloxcyt, Bilprevda, Bildyos, Ontruzant, Renflexis, Tofidence, and others listed on their referral forms.

Differentiator

Problem solved

Functional benefit

Products and services

• Specialty Pharmacy Dispensing & Patient Support Services Direct dispensing of specialty and orphan medications to patients with rare and complex diseases, including insurance/benefits navigation, prior authorization handling, financial assistance coordination, medication education, temperature-controlled home delivery, and ongoing adherence support for patients starting complex therapies.
• Prescriber Referral & Benefits Investigation Services Services for physicians, nurse practitioners, and care teams that accept specialty referrals via fax, e-prescribe (NPI 1093424905), or verbal orders. Includes benefits investigation, prior authorizations and appeals management, enrollment in patient assistance, emergency access, and bridge programs, and real-time referral status visibility.
• Manufacturer Partnership Programs Specialty pharmacy partnership programs for pharmaceutical and biotech manufacturers covering therapy access acceleration, patient engagement, limited-distribution and specialty-lite drug distribution, and real-time data visibility. Offered in two flexible models: an Integrated model (pharmacy, patient services, and access support combined) and an Ecosystem model (modular support that plugs into existing HUB and vendor partners).

Quantifiable outcome

• 23+ orphan drug launches completed successfully
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Pharmaceutical Manufacturers (Generic)coreStrategic or Co-development PartnerZeal partners with pharmaceutical and biotech companies for therapy access, patient engagement, and specialized distribution across rare-disease, specialty, and specialty-lite products. Offers flexible models including integrated model (pharmacy, patient services, and access support in one) and ecosystem model (modular support plugging into existing HUB and vendor partners). Works with pharmaceutical manufacturers to expand high-touch programs and services associated with their medications.
• Healthcare Providers and Provider NetworkscoreStrategic or Co-development PartnerPartners with healthcare providers and prescriber networks to enable patient referrals and coordinate care for rare disease and specialty medication therapies. Provides benefits investigation, prior authorization support, and ongoing adherence services to complement prescriber workflows.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Biologics by McKesson: Independent specialty pharmacy focused on oncology, rare disease, and complex therapies. Comparable because it dispenses high-cost specialty medications, partners with manufacturers for limited distribution, and operates with similar patient-services workflows.
• Trellis Rx (CPS Solutions): Specialty pharmacy services provider that partners with health systems for outpatient specialty pharmacy. Comparable because it works with manufacturers on limited-distribution drugs and emphasizes technology-enabled patient services, similar to Zeal's OnQueue approach.
• AllianceRx Walgreens Prime: Specialty and home delivery pharmacy joint venture with Walgreens. Comparable because it serves patients with chronic, complex, and rare conditions and offers manufacturer partnership programs for limited-distribution drugs.
• PANTHERx Rare Pharmacy: Specialty pharmacy specializing in rare and orphan disease therapies. Directly comparable because Zeal's founders (Ogurchak and Harper) personally built operations at PANTHERx before founding Zeal, and PANTHERx occupies the same rare-disease specialty pharmacy niche.

Broad incumbents

• Optum Specialty Pharmacy (formerly Diplomat): Specialty pharmacy operated by Optum Rx (UnitedHealth Group), which acquired Diplomat, a historically rare-disease-focused specialty pharmacy. Comparable as a payer-owned incumbent competing for the same rare-disease distribution business.
• CVS Specialty (Caremark): Specialty pharmacy arm of CVS Health/Caremark. Comparable as a large incumbent in the same specialty pharmacy category that Zeal competes in, with deeper payer affiliation and broader formulary access.
• Cigna Specialty Pharmacy (Express Scripts): Specialty pharmacy operations of Cigna/Express Scripts. Comparable as a payer/PBM-owned incumbent in the specialty pharmacy category, with structural advantages in formulary access and manufacturer contracting.
• Accredo (Evernorth/Express Scripts): One of the largest specialty pharmacies in the US, owned by Evernorth/Express Scripts. Directly comparable because Zeal's founders also built programs at Accredo; Accredo handles broad specialty distribution plus rare-disease therapies at scale that Zeal is targeting.
• Humana Specialty Pharmacy / CenterWell: Specialty and home delivery pharmacy operations of Humana/CenterWell. Comparable as a payer-affiliated specialty pharmacy competing in the same limited-distribution and rare-disease categories.
• Walgreens Specialty Pharmacy: Specialty pharmacy division of Walgreens. Comparable as a major retail-affiliated specialty pharmacy competing for limited-distribution drug partnerships and serving rare-disease patients nationwide.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/zeal-specialty-pharmacy
• Facebookfacebook.com/zealspecialty

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zeal Specialty Pharmacy